EGFR and adenocarcinoma: This approach was then used for profiling the membrane proteinof sEVs isolated from NSCLC H1975 cell culture media after treatmentwith the EGFR-TKIs erlotinib and osimertinib, as well as sEVs obtainedfrom PE-fluid of NSCLC adenocarcinoma patients.